Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

FHS
July 16, 2024
4:50 pm

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.

Toripalimab by Shanghai Junshi Biosciences for Prostate Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

Adakitug by Bristol-Myers Squibb for Hormone-Sensitive Prostate Cancer: Likelihood of Approval

Adakitug is under clinical development by Bristol-Myers Squibb and currently in Phase II for Hormone-Sensitive Prostate Cancer.

June 20, 2024

Terns Pharmaceuticals touts mid-stage success for NASH drug, stock falls

Terns Pharmaceuticals said a high dose of its experimental oral NASH treatment helped reduce liver fat in a Phase IIa trial. The Foster City, CA-based

August 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.